…evere refractory autoimmune diseases in the Breakfree-1 trial ( NCT05869955). We present updated SSc cohort data.Material and Methods This …
All extracted funders
Showing 541–600 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
Articles mentioning funders
5,089 articles · page 192 of 425…s are limited.Methods BIC-LASTING (GS-IT-380-7317, sponsored by Gilead Sciences) is a retrospective analysis on people with HIV (PWH) enrolled …
…ost responses in severe COVID-19.This work was supported by the Italian Ministry of Health (R.I.Pr.E.I. 2023_88a81b92ca9f to LF).…
…ngs suggest GLP-1s could contribute to achieving the fourth 90% UNAIDS target, historically reached mainly through psychosocial approa…
…position of the educational team (Local Health Authority – LHA, Civil Society Organisations – CSO, teachers) and the context (e.g. type of school, location, depr…
…ests for HIV and HCV, and HBsAg for HBV. The project, funded by Gilead Sciences, ran in 2025 and involved third sector organisations, healthcar…
… significantly enhanced scalability of long-acting ART within a publicly funded healthcare system without compromising virological effectiveness.Abstract OC71 Ta…
…ential therapeutic advances for fatigue in SSc patients.Funding Kaye Grant/Arthritis Society…
…this trial in the context of the clinical evidence base.Funding GSK (GSK Study 219961).Abstract P.113 Table 1Study eligibility crit…
… October 2023 – April 2024. Ethical approval was granted by the Health Research Authority and Health and Care Research Wales (REC Reference 23/NW/0206). …
…d other SSc specialist centres. It was disseminated via EUSTAR, LinkedIn, the British Society of Rheumatology SSc Specialist Interest Gr…